One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-148039
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 16 |
Affiliation: University Medical Center Groningen, Northwestern University, Institut d'Investigació Biomédica de Bellvitge, University of Barcelona, Institut Català d'Oncologia, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Tennessee Oncology, Sarah Cannon, Moffitt Cancer Center, Washington University in St. Louis, Peter MacCallum Cancer Centre, University of Melbourne, Royal Melbourne Hospital, University of Rochester, University of Chicago Medical Center, Utrecht University, Hackensack University Medical Center, Stanford University, University of Kansas Cancer Center, University of Maryland, Baltimore, Vancouver General Hospital, University of British Columbia, University of Iowa, University Hospitals Birmingham NHS Foundation Trust, Vanderbilt University, Swedish Medical Center, Amsterdam University Medical Centers, University of AmsterdamPrimary Analysis of ZUMA-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
